Kairi Beck

Kairi Beck is a finance professional with extensive experience in the biotechnology and auditing sectors. Currently serving as the Director of Finance at Variant Bio since April 2023, Kairi has previously held positions at Neoleukin Therapeutics from July 2020 to April 2023, including roles such as Director, Controller, and Senior Manager of External Reporting and Compliance. Prior to that, Kairi spent nearly seven years at EY in various assurance roles, culminating as Assurance Manager. Kairi's earlier experience includes serving as a Teaching Assistant at the University of North Carolina Wilmington and as an Assurance Intern at Ernst & Young. Kairi holds a Master of Science in Accounting and a Bachelor of Science in Business Administration with a focus on Accountancy, both from the University of North Carolina Wilmington.